Ignite Creation Date:
2024-05-06 @ 2:58 AM
Last Modification Date:
2024-10-26 @ 11:26 AM
Study NCT ID:
NCT02174822
Status:
COMPLETED
Last Update Posted:
2022-02-18
First Post:
2014-06-23
Brief Title:
A Phase 1 Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects
Sponsor:
Otsuka Pharmaceutical Development Commercialization Inc
Organization:
Otsuka Pharmaceutical Development Commercialization Inc
Study Overview
Official Title:
A Phase 1 Single-center Open-label Sequential Drug Interaction Study Between AVP-786 Deuterated d6 Dextromethorphan Hydrobromide DMQuinidine Sulfate Q and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2014-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess steady state pharmacokinetics PK safety and tolerability between AVP-786 deuterated d6 dextromethorphan hydrobromide DMquinidine sulfate Q and paroxetine and between AVP-786 and duloxetine
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None